Top

Published in:

01-11-2012 | Report

Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop

Authors: Robert Bell, Reinier Beeuwkes, Hans Erik Bøtker, Sean Davidson, James Downey, David Garcia-Dorado, Derek J. Hausenloy, Gerd Heusch, Borja Ibanez, Masafumi Kitakaze, Sandrine Lecour, Robert Mentzer, Tetsuji Miura, Lionel Opie, Michel Ovize, Marisol Ruiz-Meana, Rainer Schulz, Richard Shannon, Malcolm Walker, Jakob Vinten-Johansen, Derek Yellon

Published in: Basic Research in Cardiology | Issue 6/2012

Excerpt

The 7th biennial Hatter Cardiovascular Institute Workshop, comprising 21 leading basic science and clinical experts, was held in South Africa in August 2012 to discuss the current cutting edge status of cardioprotection and the application of cardioprotective modalities in the clinical management of myocardial ischaemia/reperfusion injury in the context of acute coronary syndromes and cardiac surgery. The meeting, chaired by Professor Derek Yellon and Professor Lionel Opie, was run to a format of previous Hatter Cardiovascular workshops with data presented by proponents followed by discussion and debate by the faculty. …

Ali MA, Cho WJ, Hudson B, Kassiri Z, Granzier H, Schulz R (2011) Titin is a target of matrix metalloproteinase-2: implications in myocardial ischemia/reperfusion injury. Circulation 122:2039–2047. doi:10.1161/CIRCULATIONAHA.109.930222 CrossRef

Amabile N, Rautou PE, Tedgui A, Boulanger CM (2010) Microparticles: key protagonists in cardiovascular disorders. Semin Thromb Hemost 36:907–916. doi:10.1055/s-0030-1267044 PubMedCrossRef

Aragon JP, Condit ME, Bhushan S, Predmore BL, Patel SS, Grinsfelder DB, Gundewar S, Jha S, Calvert JW, Barouch LA, Lavu M, Wright HM, Lefer DJ (2011) Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. J Am Coll Cardiol 58:2683–2691. doi:10.1016/j.jacc.2011.09.033 PubMedCrossRef

Azarashvili T, Baburina Y, Grachev D, Krestinina O, Evtodienko Y, Stricker R, Reiser G (2011) Calcium-induced permeability transition in rat brain mitochondria is promoted by carbenoxolone through targeting connexin43. Am J Physiol Cell Physiol 300:C707–C720. doi:10.1152/ajpcell.00061.2010 PubMedCrossRef

Basalay M, Barsukevich V, Mastitskaya S, Mrochek A, Pernow J, Sjoquist PO, Ackland GL, Gourine AV, Gourine A (2012) Remote ischaemic pre- and delayed postconditioning—similar degree of cardioprotection but distinct mechanisms. Exp Physiol 97:908–917. doi:10.1113/expphysiol.2012.064923 PubMedCrossRef

Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P, Konietzka I, Lopez-Iglesias C, Garcia-Dorado D, Di Lisa F, Heusch G, Schulz R (2005) Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res 67:234–244. doi:10.1016/j.cardiores.2005.04.014 PubMedCrossRef

Boengler K, Ruiz-Meana M, Gent S, Ungefug E, Soetkamp D, Miro-Casas E, Cabestrero A, Fernandez-Sanz C, Semenzato M, Lisa FD, Rohrbach S, Garcia-Dorado D, Heusch G, Schulz R, Mercola M (2012) Mitochondrial connexin 43 impacts on respiratory complex I activity and mitochondrial oxygen consumption. J Cell Mol Med 16:1649–1655. doi:10.1111/j.1582-4934.2011.01516.x PubMedCrossRef

Boengler K, Schulz R, Heusch G (2009) Loss of cardioprotection with ageing. Cardiovasc Res 83:247–261. doi:10.1093/cvr/cvp033 PubMedCrossRef

Boengler K, Stahlhofen S, van de Sand A, Gres P, Ruiz-Meana M, Garcia-Dorado D, Heusch G, Schulz R (2009) Presence of connexin 43 in subsarcolemmal, but not in interfibrillar cardiomyocyte mitochondria. Basic Res Cardiol 104:141–147. doi:10.1007/s00395-009-0007-5 PubMedCrossRef

10.

Chetty C, Bhoopathi P, Lakka SS, Rao JS (2007) MMP-2 siRNA induced Fas/CD95-mediated extrinsic II apoptotic pathway in the A549 lung adenocarcinoma cell line. Oncogene 26:7675–7683. doi:10.1038/sj.onc.1210584 PubMedCrossRef

11.

Grossman AN, Opie LH, Beshansky JR, Rackley CE, Ingwall SS, Selker HP (2012) Glucose-insulin-potassium revived: current status in acute coronary syndromes and the failing heart. Circulation (in press)

12.

Hearse DJ, Yellon DM, Downey JM (1986) Can beta blockers limit myocardial infarct size? Eur Heart J 7:925–930PubMed

13.

Heinzel FR, Luo Y, Li X, Boengler K, Buechert A, Garcia-Dorado D, Di Lisa F, Schulz R, Heusch G (2005) Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res 97:583–586. doi:10.1161/01.RES.0000181171.65293.65 PubMedCrossRef

14.

Heusch G (2011) Beta3-adrenoceptor activation just says NO to myocardial reperfusion injury. J Am Coll Cardiol 58:2692–2694. doi:10.1016/j.jacc.2011.09.034 PubMedCrossRef

15.

Heusch G (2012) Cardioprotection—chances and challenges of its translation to the clinic. Lancet (in press)

16.

Heusch G, Buchert A, Feldhaus S, Schulz R (2006) No loss of cardioprotection by postconditioning in connexin 43-deficient mice. Basic Res Cardiol 101:354–356. doi:10.1007/s00395-006-0589-0 PubMedCrossRef

17.

Heusch G, Kleinbongard P, Bose D, Levkau B, Haude M, Schulz R, Erbel R (2009) Coronary microembolization: from bedside to bench and back to bedside. Circulation 120:1822–1836. doi:10.1161/CIRCULATIONAHA.109.888784 PubMedCrossRef

18.

Heusch G, Kleinbongard P, Skyschally A, Levkau B, Schulz R, Erbel R (2012) The coronary circulation in cardioprotection: more than just one confounder. Cardiovasc Res 94:237–245. doi:10.1093/cvr/cvr271 PubMedCrossRef

19.

Ibanez B, Cimmino G, Prat-Gonzalez S, Vilahur G, Hutter R, Garcia MJ, Fuster V, Sanz J, Badimon L, Badimon JJ (2011) The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol 147:428–432. doi:10.1016/j.ijcard.2009.09.551 PubMedCrossRef

20.

Kandasamy AD, Schulz R (2009) Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts. Cardiovasc Res 83:698–706. doi:10.1093/cvr/cvp175 PubMedCrossRef

21.

Miro-Casas E, Ruiz-Meana M, Agullo E, Stahlhofen S, Rodriguez-Sinovas A, Cabestrero A, Jorge I, Torre I, Vazquez J, Boengler K, Schulz R, Heusch G, Garcia-Dorado D (2009) Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake. Cardiovasc Res 83:747–756. doi:10.1093/cvr/cvp157 PubMedCrossRef

22.

Musiolik J, van Caster P, Skyschally A, Boengler K, Gres P, Schulz R, Heusch G (2010) Reduction of infarct size by gentle reperfusion without activation of reperfusion injury salvage kinases in pigs. Cardiovasc Res 85:110–117. doi:10.1093/cvr/cvp271 PubMedCrossRef

23.

Ong SB, Hall AR, Hausenloy DJ (2012) Mitochondrial dynamics in cardiovascular health and disease. Antioxid Redox Signal. doi:10.1089/ars.2012.4777 PubMed

24.

Ong SB, Hausenloy DJ (2010) Mitochondrial morphology and cardiovascular disease. Cardiovasc Res 88:16–29. doi:10.1093/cvr/cvq237 PubMedCrossRef

25.

Ong SB, Subrayan S, Lim SY, Yellon DM, Davidson SM, Hausenloy DJ (2010) Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 121:2012–2022. doi:10.1161/CIRCULATIONAHA.109.906610 PubMedCrossRef

26.

Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, Ruiz-Meana M, Konietzka I, Miro E, Totzeck A, Heusch G, Schulz R, Garcia-Dorado D (2006) Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res 99:93–101. doi:10.1161/01.RES.0000230315.56904.de PubMedCrossRef

27.

Rottlaender D, Boengler K, Wolny M, Michels G, Endres-Becker J, Motloch LJ, Schwaiger A, Buechert A, Schulz R, Heusch G, Hoppe UC (2010) Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes. J Clin Invest 120:1441–1453. doi:10.1172/JCI40927 PubMedCrossRef

28.

Rottlaender D, Boengler K, Wolny M, Schwaiger A, Motloch LJ, Ovize M, Schulz R, Heusch G, Hoppe UC (2012) Glycogen synthase kinase 3beta transfers cytoprotective signaling through connexin 43 onto mitochondrial ATP-sensitive K+ channels. Proc Nat Acad Sci USA 109:E242–E251. doi:10.1073/pnas.1107479109 PubMedCrossRef

29.

Roubille F, Franck-Miclo A, Covinhes A, Lafont C, Cransac F, Combes S, Vincent A, Fontanaud P, Sportouch-Dukhan C, Redt-Clouet C, Nargeot J, Piot C, Barrere-Lemaire S (2011) Delayed postconditioning in the mouse heart in vivo. Circulation 124:1330–1336. doi:10.1161/CIRCULATIONAHA.111.031864 PubMedCrossRef

30.

Roubille F, Lairez O, Mewton N, Rioufol G, Ranc S, Sanchez I, Cung TT, Elbaz M, Piot C, Ovize M (2012) Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: a retrospective analysis. Basic Res Cardiol 107:275. doi:10.1007/s00395-012-0275-3 PubMedCrossRef

31.

Sawicki G, Leon H, Sawicka J, Sariahmetoglu M, Schulze CJ, Scott PG, Szczesna-Cordary D, Schulz R (2005) Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2. Circulation 112:544–552. doi:10.1161/CIRCULATIONAHA.104.531616 PubMedCrossRef

32.

Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D’Agostino RB, Ruthazer R, Atkins JM, Sayah AJ, Levy MK, Richards ME, Aufderheide TP, Braude DA, Pirrallo RG, Doyle DD, Frascone RJ, Kosiak DJ, Leaming JM, Van Gelder CM, Walter GP, Wayne MA, Woolard RH, Opie LH, Rackley CE, Apstein CS, Udelson JE (2012) Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA 307:1925–1933. doi:10.1001/jama.2012.426 PubMedCrossRef

33.

Sodi-Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, Friedland C, De Micheli A (1962) Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction. A preliminary clinical report. Am J Cardiol 9:166–181PubMedCrossRef

34.

Sung MM, Schulz CG, Wang W, Sawicki G, Bautista-Lopez NL, Schulz R (2007) Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. J Mol Cell Cardiol 43:429–436. doi:10.1016/j.yjmcc.2007.07.055 PubMedCrossRef

35.

Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R (2002) Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 106:1543–1549. doi:10.1161/01.CIR.0000028818.33488.7B PubMedCrossRef

36.

Whittington HJ, Babu GG, Mocanu MM, Yellon DM, Hausenloy DJ (2012) The diabetic heart: too sweet for its own good? Cardiol Res Pract 2012:845698. doi:10.1155/2012/845698 PubMed

Title: Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop
Authors: Robert Bell
Reinier Beeuwkes
Hans Erik Bøtker
Sean Davidson
James Downey
David Garcia-Dorado
Derek J. Hausenloy
Gerd Heusch
Borja Ibanez
Masafumi Kitakaze
Sandrine Lecour
Robert Mentzer
Tetsuji Miura
Lionel Opie
Michel Ovize
Marisol Ruiz-Meana
Rainer Schulz
Richard Shannon
Malcolm Walker
Jakob Vinten-Johansen
Derek Yellon
Publication date: 01-11-2012
Publisher: Springer-Verlag
Published in: Basic Research in Cardiology / Issue 6/2012
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-012-0300-6

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2012

Molecular and cellular mechanisms of macrophage survival in atherosclerosis

Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion

Increased afterload induces pathological cardiac hypertrophy: a new in vitro model

Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products

Saphenous vein aorto-coronary graft atherosclerosis in patients with chronic kidney disease: more plaque calcification and necrosis, but less vasoconstrictor potential

Cardiomyocyte-specific deletion of survivin causes global cardiac conduction defects

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page